UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
(Name
of Issuer)
|
(Title
of Class of Securities)
|
(CUSIP
Number)
|
(Name,
Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
|
(Date
of Event which Requires Filing of this
Statement)
|
If
the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or
240.13d-1(g), check the following box o
The
information required on the remainder of this cover page shall not be
deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities
of that section of the Act but shall be subject to all other provisions of
the Act.
|
CUSIP No. 37929X
107
|
Page 2 of
11 Pages
|
||||
|
|
||||
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS
Martin
E. Franklin
|
||||
|
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A
GROUP* (a)
o
|
||||
|
|
||||
3
|
SEC
USE ONLY
|
||||
|
|
||||
4
|
SOURCE
OF FUNDS
OO
|
||||
|
|
||||
5
|
|||||
|
|
||||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
Kingdom
|
||||
|
|
||||
NUMBER
OF
SHARES
|
7
|
SOLE
VOTING POWER
-0-
(See Item 5)
|
|||
|
|
||||
BENEFICIALLY
OWNED
BY
|
8
|
SHARED
VOTING POWER
|
|||
|
|
||||
EACH
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
14,337,228 3 (See Item
5)
|
|||
|
|
||||
PERSON
WITH
|
10
|
SHARED
DISPOSITIVE POWER
-0-
|
|||
|
|
|
|||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,637,228
(See Item 5)
|
||||
|
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
|
||||
|
|
||||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.6%
of outstanding shares of Common Stock4
|
||||
|
|
||||
14
|
TYPE
OF REPORTING PERSON
IN
|
||||
|
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page 3 of
11 Pages
|
Item 1.
|
Security and
Issuer.
|
1
|
Excludes
as outstanding shares 58,904,993 shares of Common Stock into which all
Exchangeable Securities are exchangeable and 8,064,516 shares of Common
Stock issuable upon conversion of the Notes and includes 2,000,000,
1,800,000 and 4,738,560 shares of Common Stock issuable upon exercise of
Co-Investment Warrants, Sponsors' Warrants and Founders' Warrants,
respectively, held by Franklin. The percentage is based on
261,197,179 shares of common stock outstanding, which consists of (i)
252,658,619 shares outstanding as represented by the Issuer and (ii)
8,538,560 shares of Common Stock issuable upon exercise of warrants to
purchase common stock held by Franklin. Including as
outstanding shares 58,904,993 shares of Common Stock into which all
Exchangeable Securities are exchangeable, the percentage would be
4.6%.
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page 4 of
11 Pages
|
Item 2.
|
Identity and
Background.
|
Item
4.
|
Purpose of
Transaction.
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page 5 of
11 Pages
|
Item 5.
|
Interest in Securities
of the Issuer.
|
(i)
|
Amount
beneficially owned: 14,637,228
shares
|
(ii)
|
Percent
of class: 5.6% of outstanding shares of Common Stock1
|
(iii)
|
Number
of shares as to which such person
has:
|
(a)
|
Sole
power to vote or direct the vote:
-0-
|
(b)
|
Shared
power to vote or direct the vote: 174,261,033 shares (consisting of 174,
261,033 shares of voting stock (including (1) Exchangeable Securities
which are exchangeable for 58,904,993 shares of Common Stock, (2) $30
million aggregate
|
1
|
Excludes
as outstanding shares 58,904,993 shares of Common Stock into which all
Exchangeable Securities are exchangeable and 8,064,516 shares of Common
Stock issuable upon conversion of the Notes. The percentage is
based on 261,197,179 shares of common stock outstanding, which consists of
(i) 252,658,619 shares outstanding as of December 31, 2009 as represented
by the Issuer and (ii) 8,538,560 shares of Common Stock issuable upon
exercise of warrants to purchase common stock held by
Franklin. Including as outstanding shares 58,904,993 shares of
Common Stock into which all Exchangeable Shares are exchangeable, the
percentage would be 4.6%.
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page 6 of
11 Pages
|
|
principal
amount of the Notes, which are convertible into 8,064,516 shares of Common
Stock, (3) 1,800,000 Sponsors’ Warrants to purchase 1,800,000 shares of
Common Stock, (4) 2,000,000 Co-Investment Warrants to purchase 2,000,000
shares of Common Stock and (5) 4,738,560 Founders’ Warrants to purchase
4,738,560 shares of Common Stock2) held by the parties to the Voting
Agreement)
|
(c)
|
Sole
power to dispose or direct the disposition: 14,337,228 shares3
|
(d)
|
Shared
power to dispose or direct the
disposition: -0-
|
Item
6.
|
Contracts,
Arrangements, Understandings or Relationships with Respect to Securities
of the Issuer.
|
3
|
Excludes
300,000 shares of restricted Common Stock over which Franklin does not
have dispositive power prior to their vesting in three equal installments
on each of May 15, 2010, 2011 and
2012.
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page
7 of 11 Pages
|
·
|
the
nomination, designation or election of the members of the board of
directors of the Issuer (or the board of any subsidiary) or their
respective successors (or their
replacements);
|
·
|
the
removal, with or without cause, from the board of directors (or the board
of any subsidiary) of any director;
and
|
·
|
any
change in control of the Issuer.
|
·
|
any
incurrence of indebtedness, in one transaction or a series of related
transactions, by the Issuer or any of its subsidiaries in excess of $570.0
million or, if a greater amount has been previously approved by the
controlling stockholders and their respective permitted transferees, such
greater amount;
|
·
|
any
issuance by the Issuer of equity or equity-related securities that would
represent, after such issuance, or upon conversion, exchange or exercise,
as the case may be, at least 20% of the total voting power of the Issuer,
other than (1) pursuant to transactions solely among the Issuer and its
wholly-owned subsidiaries, and (2) upon conversion of convertible
securities or upon exercise of warrants or
options;
|
·
|
any
commitment to invest or investment or series of related commitments to
invest or investments in a person or group of related persons in an amount
greater than $250.0 million;
|
·
|
the
adoption of a shareholder rights
plan;
|
·
|
any
appointment of a Chief Executive Officer or Co-Chief Executive Officer of
the Issuer; or
|
·
|
the
termination of the employment of a Principal with the Issuer or any of its
material subsidiaries without
cause.
|
·
|
more
than 50% of the total voting power of the Issuer, the Issuer will nominate
individuals designated by the Voting Block such that the controlling
stockholders will have six designees on the board of directors if the
number of directors is ten or eleven, or five designees on the board if
the number of directors is nine or less and, in each case, assuming such
nominees are elected;
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page 8 of
11 Pages
|
·
|
between
40% and 50% of the total voting power of the Issuer, the Issuer will
nominate individuals designated by the Voting Block such that the
controlling stockholders will have five designees on the board of
directors if the number of directors is ten or eleven, or four designees
on the board if the number of directors is nine or less and, in each case,
assuming such nominees are elected;
|
·
|
between
25% and 40% of the total voting power of the Issuer, the Issuer will
nominate individuals designated by the Voting Block such that the
controlling stockholders will have four designees on the board of
directors if the number of directors is ten or eleven, or three designees
on the board if the number of directors is nine or less and, in each case,
assuming such nominees are elected;
|
·
|
between
10% and 25% of the total voting power of the Issuer, the Issuer will
nominate individuals designated by the Voting Block such that the
controlling stockholders will have two designees on the board of
directors, assuming such nominees are elected;
and
|
·
|
less
than 10% of the total voting power of the Issuer, the Issuer will have no
obligation to nominate any individual that is designated by the
controlling stockholders.
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page 9 of
11 Pages
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page 10 of
11 Pages
|
Item
7.
|
Material to be Filed
as Exhibits.
|
Exhibit
1.
|
Amendment
No. 1 and Joinder to the Voting Agreement, dated as of February 12, 2010,
among the Reporting Person, the other Voting Agreement Parties and the
Issuer included as Exhibit 10.1 to the Current Report on Form 8-K of the
Issuer (File No. 001-33217) filed on February 19, 2010, is incorporated
herein by reference.
|
CUSIP
NO. 37929X 107
|
SCHEDULE
13D
|
Page 11 of
11 Pages
|
Dated: February
19, 2010
|
By: /s/
Martin E.
Franklin
Martin
E. Franklin
|